Yüklüyor......
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence
Psoriasis (PsO) is a common, systemic, chronic, inflammatory disease characterized by key clinical symptoms, including itching, pain, and scaling. PsO is associated with a high prevalence of comorbidities, including other autoimmune diseases and malignancies. Furthermore, special populations, such a...
Kaydedildi:
| Yayımlandı: | Dermatol Ther (Heidelb) |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Healthcare
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7211772/ https://ncbi.nlm.nih.gov/pubmed/32242325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-020-00373-z |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|